Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Zhi-Ling Li

Regorafenib Promotes Anti-Tumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma

Clinical Cancer Research

Cancer Research

English

Related publications

Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression

Molecular Biology

English

CMTM6 Maintains the Expression of PD-L1 and Regulates Anti-Tumour Immunity

Multidisciplinary

English

PD-L1 Expression by Tumor Cell-Lines: A Predictive Marker in Melanoma

Experimental Dermatology

Molecular Biology

English

Targeting NKT Cells and PD-L1 Pathway Results in Augmented Anti-Tumor Responses in a Melanoma Model

Cancer Immunology, Immunotherapy

Cancer Research

English

PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison

Clinical Cancer Research

Cancer Research

English

MYC Promotes Tumorigenesis via Activation of CD47 and PD-L1

Cancer Discovery

English

P2.17-12 Eliminating Radiation Resistance of Non-Small Cell Lung Cancer by DHA Trough Abrogating Immunity Escaping via Inhibiting PD-L1 Expression

Journal of Thoracic Oncology

Respiratory Medicine

English

839 Dual Targeting Autoinflammation and PD-L1/L2 Immune Checkpoint by EGCG Augments Anti-Tumor Effects in Melanoma

Journal of Investigative Dermatology

Molecular Biology

English

123 Ubiquitination Control of Tumor Proliferation, Metastasis and Immune Escape via Prohibitin/Stat3/Pd-L1 Axis in Melanoma

Journal of Investigative Dermatology

Molecular Biology

English